Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Ambrogio

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Molecular Oncology|October 24, 2023
Exploiting signaling rewiring in cancer cells with co-existing oncogenic driversRoberto Chiarle, Chiara Ambrogio
Nature Cancer|June 27, 2023
YAP and TAZ orchestrate adaptive resistance to KRAS inhibitorsAlessia Mira, Chiara Ambrogio
The International Journal of Biochemistry & Cell Biology|December 14, 2020
Discoveries in the redox regulation of KRASMaximilian Kramer-Drauberg, Chiara Ambrogio
Translational Lung Cancer Research|September 19, 2018
Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insightsYoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi
Current Medicinal Chemistry|May 31, 2017
Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung AdenocarcinomaJens Kohler, Marco Catalano, Chiara Ambrogio
Nature Reviews. Cancer|March 7, 2025
ALK in cancer: from function to therapeutic targetingClaudia Voena, Chiara Ambrogio, Fabio Iannelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2022
The Anti-Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby BoomersRoberto Ferrara, Biagio Ricciuti, Chiara Ambrogio, et al.
Trends in Cancer|December 14, 2020
Targeting Infrequent Driver Alterations in Non-Small Cell Lung CancerMarie-Julie Nokin, Chiara Ambrogio, Ernest Nadal, et al.
Nature Cancer|February 5, 2022
A LIBRETTO to orchestrate targeted therapyMelina E Marmarelis, Roberto Chiarle, Chiara Ambrogio, et al.
Cell Adhesion & Migration|March 6, 2018
A putative role for Discoidin Domain Receptor 1 in cancer chemoresistanceChiara Ambrogio, Elodie Darbo, Sam W Lee, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Molecular Oncology|October 24, 2023
Exploiting signaling rewiring in cancer cells with co-existing oncogenic driversRoberto Chiarle, Chiara Ambrogio
Nature Cancer|June 27, 2023
YAP and TAZ orchestrate adaptive resistance to KRAS inhibitorsAlessia Mira, Chiara Ambrogio
The International Journal of Biochemistry & Cell Biology|December 14, 2020
Discoveries in the redox regulation of KRASMaximilian Kramer-Drauberg, Chiara Ambrogio
Translational Lung Cancer Research|September 19, 2018
Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insightsYoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi
Current Medicinal Chemistry|May 31, 2017
Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung AdenocarcinomaJens Kohler, Marco Catalano, Chiara Ambrogio
Nature Reviews. Cancer|March 7, 2025
ALK in cancer: from function to therapeutic targetingClaudia Voena, Chiara Ambrogio, Fabio Iannelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2022
The Anti-Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby BoomersRoberto Ferrara, Biagio Ricciuti, Chiara Ambrogio, et al.
Trends in Cancer|December 14, 2020
Targeting Infrequent Driver Alterations in Non-Small Cell Lung CancerMarie-Julie Nokin, Chiara Ambrogio, Ernest Nadal, et al.
Nature Cancer|February 5, 2022
A LIBRETTO to orchestrate targeted therapyMelina E Marmarelis, Roberto Chiarle, Chiara Ambrogio, et al.
Cell Adhesion & Migration|March 6, 2018
A putative role for Discoidin Domain Receptor 1 in cancer chemoresistanceChiara Ambrogio, Elodie Darbo, Sam W Lee, et al.
Pageof 9